Literature DB >> 19636223

Effect of short hairpin RNA-mediated adiponectin/Acrp30 down-regulation on insulin signaling and glucose uptake in the 3T3-L1 adipocytes.

K Li1, L Li, G Y Yang, H Liu, S B Li, G Boden.   

Abstract

Adiponectin is a polypeptide hormone that is secreted by adipocytes with insulin-sensitizing and anti-inflammatory properties. The current study was to further investigate the role of adiponectin on glucose uptake and its underlying mechanism by down-regulation of adiponectin in 3T3-L1 adipocytes. Transfection of short hairpin RNA (shRNA)-vector significantly decreased adiponectin mRNA expression and its protein level in the cells. The down-regulation of adiponectin markedly reduced the cellular glucose uptake rate and increased intracellular triglyceride content. To study the mechanism of the physiologic action of adiponectin, several key regulatory factors in insulin signaling pathway were examined. The mRNA expression of insulin receptor substrate (IRS)-1 in both basal and insulin-stimulated states were down-regulated in the transfected cells (72% and 52% of controls, respectively), and the insulin-stimulated IRS-1 tyrosine phosphorylation was also significantly decreased. Adiponectin-deficient cells showed marked down-regulations of peroxisome proliferator-activated receptor alpha, glucose transporter (GLUT)-1, GLUT-4, hormone-sensitive lipase (HSL), and adipose triglyceride lipase. These results thus demonstrated that transfection of shRNA-vector effectively reduced the expression of adiponectin in 3T3-L1 adipocytes accompanied with a significant decrease in cellular glucose uptake rate and an increase in intracellular triglyceride content. Our data also suggested that adiponectin deficiency impair insulin action in vitro probably through the IRS-1 pathway, and increase intracellular fat accumulation partially through HSL down-regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636223     DOI: 10.1007/BF03346561

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  How cells absorb glucose.

Authors:  G E Lienhard; J W Slot; D E James; M M Mueckler
Journal:  Sci Am       Date:  1992-01       Impact factor: 2.142

2.  Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.

Authors:  Atsushi Tsuchida; Toshimasa Yamauchi; Sato Takekawa; Yusuke Hada; Yusuke Ito; Toshiyuki Maki; Takashi Kadowaki
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter.

Authors:  Peter E H Schwarz; Gordon W Towers; Sabine Fischer; Suresh Govindarajalu; Jan Schulze; Stephan R Bornstein; Markolf Hanefeld; Francis Vasseur
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

4.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

5.  The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Authors:  Jelena Zacharova; Jean-Louis Chiasson; Markku Laakso
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

Review 6.  Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis.

Authors:  Michael W Rajala; Philipp E Scherer
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

7.  Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes.

Authors:  Xiangdong Wu; Hiroyuki Motoshima; Kalyankar Mahadev; Timothy J Stalker; Rosario Scalia; Barry J Goldstein
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

8.  Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin.

Authors:  Ke Ma; Agatha Cabrero; Pradip K Saha; Hideto Kojima; Lan Li; Benny Hung-Junn Chang; Antoni Paul; Lawrence Chan
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

9.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.

Authors:  Norikazu Maeda; Iichiro Shimomura; Ken Kishida; Hitoshi Nishizawa; Morihiro Matsuda; Hiroyuki Nagaretani; Naoki Furuyama; Hidehiko Kondo; Masahiko Takahashi; Yukio Arita; Ryutaro Komuro; Noriyuki Ouchi; Shinji Kihara; Yoshihiro Tochino; Keiichi Okutomi; Masato Horie; Satoshi Takeda; Toshifumi Aoyama; Tohru Funahashi; Yuji Matsuzawa
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  8 in total

1.  Liraglutide prevents hypoadiponectinemia-induced insulin resistance and alterations of gene expression involved in glucose and lipid metabolism.

Authors:  Ling Li; Zongyu Miao; Rui Liu; Mengliu Yang; Hua Liu; Gangyi Yang
Journal:  Mol Med       Date:  2011-07-11       Impact factor: 6.354

2.  Transcription factor TIP27 regulates glucose homeostasis and insulin sensitivity in a PI3-kinase/Akt-dependent manner in mice.

Authors:  L Yuan; X Luo; M Zeng; Y Zhang; M Yang; L Zhang; R Liu; G Boden; H Liu; Z A Ma; L Li; G Yang
Journal:  Int J Obes (Lond)       Date:  2015-01-23       Impact factor: 5.095

3.  Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARγ.

Authors:  Dong Hyun Kim; Luca Vanella; Kazuyoshi Inoue; Angela Burgess; Katherine Gotlinger; Vijaya Lingam Manthati; Sreenivasulu Reddy Koduru; Darryl C Zeldin; John R Falck; Michal L Schwartzman; Nader G Abraham
Journal:  Stem Cells Dev       Date:  2010-10-09       Impact factor: 3.272

Review 4.  Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications.

Authors:  Katarzyna Zorena; Olga Jachimowicz-Duda; Daniel Ślęzak; Marlena Robakowska; Małgorzata Mrugacz
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

5.  CILP-2 is a novel secreted protein and associated with insulin resistance.

Authors:  Tong Wu; Qin Zhang; Shaobo Wu; Wenjing Hu; Tingting Zhou; Ke Li; Dongfang Liu; Harvest F Gu; Hongting Zheng; Zhiming Zhu; Ling Li; Gangyi Yang
Journal:  J Mol Cell Biol       Date:  2019-12-19       Impact factor: 6.216

6.  Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance.

Authors:  Mengliu Yang; Lili Zhang; Chong Wang; Hua Liu; Guenther Boden; Gangyi Yang; Ling Li
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

7.  Alteration of fatty acid metabolism in the liver, adipose tissue, and testis of male mice conceived through assisted reproductive technologies: fatty acid metabolism in ART mice.

Authors:  Li-Ya Wang; Fang Le; Ning Wang; Lei Li; Xiao-Zhen Liu; Ying-Ming Zheng; Hang-Ying Lou; Xiang-Rong Xu; Yun-Long Chen; Xiao-Ming Zhu; He-Feng Huang; Fan Jin
Journal:  Lipids Health Dis       Date:  2013-01-23       Impact factor: 3.876

8.  Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-Α2-Glycoprotein Levels in Patients with Type 2 Diabetes.

Authors:  Xin Liao; Xuemei Wang; Haopeng Li; Ling Li; Guohao Zhang; Mengliu Yang; Lei Yuan; Hua Liu; Gangyi Yang; Lin Gao
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.